Literature DB >> 30027350

Knowledge of features of inflammatory back pain in primary care in the West Midlands: a cross-sectional survey in the United Kingdom.

T Adizie1, S Elamanchi2, A Prabu2, A V Pace3, R Laxminarayan4, N Barkham5.   

Abstract

KEY MESSAGES: There is a relative lack of confidence among GPs in the assessment and management of IBP vs. mechanical back pain. A simple screening tool for SpA, applicable in primary care urgently needs to be developed. It is reasonable for patients with symptoms suggestive of inflammatory back pain to be referred to secondary care without further investigations. The objective of this study was to assess current practice of our local general practitioners (GPs) in using clinical features, as well as radiological and laboratory investigations to assess patients with IBP. An online, observational questionnaire-based survey was done in 10 West Midlands CCGs including disparate geographical and socioeconomic areas. The survey consisted of 23 questions based on Calin, Berlin and ESSG Criteria for spondyloarthropathies. GPs were asked to rate the importance of a range of symptoms as indications of IBP IBP (10 point scale, range 1-10), and what their views were on which were the most important treatments for patients with suspected inflammatory back pain(4 point scale, range 1-4). The 4 most important symptoms for predicting inflammatory back pain according to our local cohort of GPs were 'morning stiffness' 'sleep disturbances caused by back pain' 'insidious onset' and 'age of onset' < 45. Among the treatment options, NSAIDs were ranked as the most important treatment option for IBP. DMARDS were rated as the next most important treatment option, ahead of physiotherapy and anti-TNF therapy. This study has highlighted relative lack of confidence among GPs in the assessment of IBP. Whether this reflects a need for education or poor performance of these questions in primary care populations requires further study.

Entities:  

Keywords:  HLA B27; Inflammatory back pain; Primary care; Spondyloarthropathy

Mesh:

Substances:

Year:  2018        PMID: 30027350     DOI: 10.1007/s00296-018-4058-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

Review 1.  Mortality, course of disease and prognosis of patients with ankylosing spondylitis.

Authors:  J Braun; T Pincus
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

2.  Clinical history as a screening test for ankylosing spondylitis.

Authors:  A Calin; J Porta; J F Fries; D J Schurman
Journal:  JAMA       Date:  1977-06-13       Impact factor: 56.272

3.  Delay to diagnosis in axial spondyloarthritis: are we improving in the UK?

Authors:  Mark P Sykes; Helen Doll; Raj Sengupta; Karl Gaffney
Journal:  Rheumatology (Oxford)       Date:  2015-08-17       Impact factor: 7.580

4.  Time to diagnosis of axial spondylarthritis in clinical practice: signs of improving awareness?

Authors:  Alexis Jones; Nikki Harrison; Tim Jones; Jonathan D Rees; Alexander N Bennett
Journal:  Rheumatology (Oxford)       Date:  2014-08-19       Impact factor: 7.580

5.  How to diagnose axial spondyloarthritis early.

Authors:  M Rudwaleit; D van der Heijde; M A Khan; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

6.  The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.

Authors:  Nigil Haroon; Robert D Inman; Thomas J Learch; Michael H Weisman; MinJae Lee; Mohammad H Rahbar; Michael M Ward; John D Reveille; Lianne S Gensler
Journal:  Arthritis Rheum       Date:  2013-10

Review 7.  Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group.

Authors:  Robert G W Lambert; Pauline A C Bakker; Désirée van der Heijde; Ulrich Weber; Martin Rudwaleit; K G Hermann; Joachim Sieper; Xenofon Baraliakos; Alex Bennett; Jürgen Braun; Rubén Burgos-Vargas; Maxime Dougados; Susanne Juhl Pedersen; Anne Grethe Jurik; Walter P Maksymowych; Helena Marzo-Ortega; Mikkel Østergaard; Denis Poddubnyy; Monique Reijnierse; Filip van den Bosch; Irene van der Horst-Bruinsma; Robert Landewé
Journal:  Ann Rheum Dis       Date:  2016-01-14       Impact factor: 19.103

8.  The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10.

Authors:  Michael H Weisman; James P Witter; John D Reveille
Journal:  Ann Rheum Dis       Date:  2012-07-11       Impact factor: 19.103

9.  Identifying patients with axial spondyloarthritis in primary care: how useful are items indicative of inflammatory back pain?

Authors:  A Braun; E Saracbasi; J Grifka; J Schnitker; J Braun
Journal:  Ann Rheum Dis       Date:  2011-08-05       Impact factor: 19.103

10.  Maximising response from GPs to questionnaire surveys: do length or incentives make a difference?

Authors:  Elizabeth Cottrell; Edward Roddy; Trishna Rathod; Elaine Thomas; Mark Porcheret; Nadine E Foster
Journal:  BMC Med Res Methodol       Date:  2015-01-06       Impact factor: 4.615

View more
  3 in total

1.  Clinical features as predictors of histologically confirmed inflammation in patients with lumbar disc herniation with associated radiculopathy.

Authors:  Jon J Ford; Omar Kaddour; Michael Gonzales; Patrick Page; Andrew J Hahne
Journal:  BMC Musculoskelet Disord       Date:  2020-08-21       Impact factor: 2.362

Review 2.  The Evolving Case Supporting Individualised Physiotherapy for Low Back Pain.

Authors:  Jon Ford; Andrew Hahne; Luke Surkitt; Alexander Chan; Matthew Richards
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

3.  Axial spondyloarthritis 10 years on: still looking for the lost tribe.

Authors:  Rosemarie Barnett; Thomas Ingram; Raj Sengupta
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.